Skip to main content

Together we are beating cancer

Donate now

Lung cancer

Lung cancer is the third most common cancer in the UK, with around 48,500 people diagnosed each year. There are two main types of lung cancer – small cell lung cancer and non small cell lung cancer – depending on how the cells look under the microscope.

The main symptoms are a cough, shortness of breath and weight loss.

Showing 12 out of 355 results
DNA fingerprint
  • Science & Technology
  • Health & Medicine

Watching cancers evolve using ‘liquid biopsies’

Tumours release DNA into the bloodstream, and scientists have been investigating whether this could offer clues about a cancer - take a look at what they found. Tumours release DNA into the bloodstream, and scientists have been investigating whether this could offer clues about a cancer - take a look at what they found.

by Henry Scowcroft | Analysis | 8 April 2013

8 April 2013

Cancer Research UK logo

The cost of lung cancer to the UK economy is Ј2.4 billion each year, far higher than the cost of any other cancer. This highlights the urgent need to continue to reduce the number of young people who become addicted to tobacco – as smoking causes more than eight in 10 lung cancers in the UK. The cost of lung cancer to the UK economy is Ј2.4 billion each year, far higher than the cost of any other cancer. This highlights the urgent need to continue to reduce the number of young people who become addicted to tobacco – as smoking causes more than eight in 10 lung cancers in the UK.

by The National Cancer Research Institute (NCRI) | News | 7 November 2012

7 November 2012

Cancer Research UK logo

The same protein could potentially be targeted to detect precancerous breast cells; deliver radiotherapy to destroy tumours; and monitor the effectiveness of treatment, according to a Cancer Research UK study presented at the NCRI Cancer Conference in Liverpool today. The same protein could potentially be targeted to detect precancerous breast cells; deliver radiotherapy to destroy tumours; and monitor the effectiveness of treatment, according to a Cancer Research UK study presented at the NCRI Cancer Conference in Liverpool today.

by The National Cancer Research Institute (NCRI) | News | 6 November 2012

6 November 2012